YOLFTbeta
Gasporox AB (publ)

Gasporox AB (publ)

GPX · ST · Technology / Scientific & Technical Instruments

3.84SEK-0.42 (-9.86%)

Price History

Full chart

Market Stats

Previous Close4.26
Open4.26
Day Range3.84 – 4.26
52-Week Range5.05 – 9.40
Volume9.13K
Market Cap60.33M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.50
Dividend Yield0.00%
Beta0.75
50-Day Avg6.24
200-Day Avg7.11

About

Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500. Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.

Company Details

  • SectorTechnology
  • IndustryScientific & Technical Instruments
  • CEODr. Marta Lewander Xu Ph.D.
  • Employees22
  • HeadquartersTellusgatan 13, Lund, Sweden, 224 57, Sweden
  • Websitehttps://www.gasporox.se

Leadership

  • Dr. Marta Lewander Xu Ph.D.Chief Executive Officer · b. 1981
  • Fredrik HanssonChief Financial Officer · b. 1991
  • Mr. Roland KochVP and Director of Sales & Applications
  • Ms. Hanna SjostromChief Executive Officer of GPX Medical AB · b. 1979

Financials

Income Statement

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue383.53K1.27M1.22M2.24M5.03M6.29M10.21M12.45M15.74M21.45M31.43M34.10M31.57M
Growth (%)-+229.85%-3.96%+84.20%+124.80%+24.95%+62.34%+22.03%+26.39%+36.27%+46.53%+8.51%-7.42%
Cost of Revenue164.82K252.12K-620.00K374.00K-2.41M-2.79M-282.00K-707.00K-524.00K-1.00M735.00K1.00M35.01M
Gross Profit218.71K1.01M1.83M1.86M7.44M9.08M10.49M13.16M16.26M22.45M30.69M33.10M-3.43M
Gross Margin57.03%80.07%151.03%83.29%147.82%144.43%102.76%105.68%103.33%104.67%97.66%97.06%-10.87%
Operating Expense2.68M4.82M5.22M5.64M12.82M15.70M18.72M17.52M21.65M26.68M31.27M35.29M4.55M
Operating Income-2.46M-3.81M-3.38M-3.78M-5.38M-6.63M-8.23M-4.36M-5.39M-4.23M-576.00K-2.18M-7.98M
Operating Margin-640.64%-301.00%-278.52%-168.77%-107.02%-105.39%-80.69%-35.02%-34.25%-19.71%-1.83%-6.40%-25.27%
EBITDA-1.76M-46.58K-2.03M-2.35M-3.78M-4.50M-5.14M-3.82M-4.69M-3.25M946.00K-347.00K-1.55M
EBITDA Margin-458.14%-3.68%-167.16%-104.87%-75.13%-71.65%-50.41%-30.65%-29.80%-15.18%3.01%-1.02%-4.93%
Net Income-2.44M-3.85M-3.51M-3.76M-5.13M-6.32M-7.17M-4.36M-5.39M-4.56M-1.25M-2.68M-7.71M
Net Income Margin-636.76%-304.68%-289.05%-168.14%-102.05%-100.57%-70.29%-35.04%-34.26%-21.25%-3.96%-7.85%-24.42%
R&D----1.21M1.69M1.96M2.73M1.97M2.37M2.83M--
R&D as % of Total Revenue----23.97%26.93%19.16%21.94%12.52%11.03%9.01%--
Interest Expense--128.00K01.00K1.00K7.00K1.00K1.00K174.00K803.00K677.00K1.72M
Interest Expense % of Total Revenue--10.53%0.00%0.02%0.02%0.07%0.01%0.01%0.81%2.56%1.99%5.45%

Balance Sheet

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.29M5.26M5.68M20.50M19.33M31.57M39.79M41.14M37.37M44.43M43.52M39.97M50.62M
Total Liabilities1.74M4.86M1.35M3.74M4.95M4.85M6.82M7.07M8.74M19.99M20.33M13.28M30.76M
Total Equity1.54M404.00K4.33M16.76M13.77M22.96M29.42M34.07M28.63M24.44M23.19M26.69M19.86M
Cash724.88K383.00K222.00K11.00M8.39M16.60M17.68M24.23M14.27M14.56M10.62M6.81M6.65M
Total Debt-4.04M769.00K-1.00M----8.43M8.73M2.32M15.22M
Net Debt-724.88K3.65M547.00K-11.00M-7.39M-16.60M-17.68M-24.23M-14.27M-6.13M-1.90M-4.49M8.57M

Cash Flow

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---5.73M-4.36M-1.10M-5.98M-4.66M-642.00K-3.39M-1.19M3.34M4.36M-4.72M
Investing Cash Flow---1.86M-1.05M-4.51M-4.78M-6.01M-5.45M-6.52M-7.01M-7.04M-7.52M-7.65M
Financing Cash Flow--7.44M16.19M3.00M18.97M11.75M18.00M-53.00K8.50M-240.00K-648.00K12.21M
Capital Expenditure001.86M1.05M4.51M4.78M6.01M5.45M6.52M7.09M975.00K7.88M4.72M
Free Cash Flow---7.60M-5.42M-5.61M-10.76M-10.67M-6.09M-9.91M-8.28M-3.98M-3.52M-12.52M
FCF to OCF--132.49%124.11%508.98%179.89%229.12%948.75%292.07%695.63%-119.18%-80.74%265.23%

Earnings

Report DateDec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Nov 4, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Feb 17, 2022May 10, 2022Aug 30, 2022Nov 10, 2022Feb 28, 2023Apr 27, 2023Aug 9, 2023Nov 7, 2023Feb 15, 2024Apr 23, 2024Aug 7, 2024Oct 24, 2024Feb 13, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual-0.33-0.25-0.22-0.07-0.55-0.37-0.37-0.22-0.26-0.23-0.41-0.03-0.48-0.16-0.36-0.190.01-0.14-0.32-0.220.06-0.13-0.270.03-0.140.16-0.10-0.11-0.100.00-0.01-0.17-0.12-0.49-0.41-0.030.11-0.17-0.23
Surprise---------------------------------------
Timing--------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market------

Key Statistics & Ratios

Market Cap60.33M
Enterprise Value61.42M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.57
Price / Book2.90
EPS-0.50
Book Value1.72
Revenue (TTM)38.31M
Gross Profit (TTM)30.68M
EBITDA748.00K
Profit Margin-7.98%
Operating Margin-18.87%
Return on Equity-17.33%
Return on Assets-1.80%
Shares Outstanding9.35M
Shares Float3.40M
Beta0.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%